About CARVYKTI®
How CARVYKTI® works
Manufacturing CARVYKTI®
CARVYKTI® Efficacy
CARTITUDE-4
Primary Analysis
Study Design
Progression-Free Survival (PFS)
Overall Survival (OS)
Depth of Response
Duration of Response (DOR)
CARTITUDE-4
Follow-Up Analysis
Progression-Free Survival (PFS)
Overall Survival (OS)
Depth of Response
Duration of Response (DOR)
Time to Next Treatment (TTNT)
CARTITUDE-1
Primary Analysis
Study Design
Depth of Response
Duration of Response (DOR)
Time to Response
CARTITUDE-1
5-Year Follow-Up Analysis
5-Year Baseline Characteristics
5-Year Duration of Response
CARVYKTI® Safety
Boxed Warning
Cytokine Release
Syndrome (CRS)
Neurologic Toxicities
Hemophagocytic
Lymphohistiocytosis (HLH)
Prolonged and/or
Recurrent Cytopenias
Immune Effector Cell-Associated Enterocolitis
Secondary Malignancies
Additional Warnings & Precautions, and ARs ≥10%
Safety Timeline/Long-Term Safety
Treatment Process
Patient Identification
Steps in the Treatment Process
Resources
For Physicians
For Nurses and APPs
For Patients and Care Partners
Patient Support Program
For Access and Reimbursement Support
For Order Management
Support for Nurses & APPs
Urgency to Treat Earlier
Attrition Rates
T-cell Fitness and Bridging Therapy
Treatment Centers
Coverage Lookup
Get In Touch
CARVYKTI® Prescribing Information
FAQs
Contact Us
Go To Patient Website

You’re more powerful than you think

As a nurse or APP, you’re at the heart of every patient’s journey. From the first CARVYKTI^® conversation to infusion and AE monitoring, your expertise helps shape each step and every outcome.

To help you make the most of every moment, this page puts the right tools and resources at your fingertips—for every stage of care, from early identification to long-term follow-up.

Nurse-led education for CARVYKTI^®

As central members of the CAR‑T care team, nurses and APPs help shape the patient experience from referral through long‑term follow‑up. These sessions feature our nurse educators discussing critical topics in CARVYKTI^® management, delivering practical strategies to support safe, informed, and effective care at every step of the treatment journey.

Medical professional speaking with patient

CARVYKTI^® Patient Eligibility

This educational video provides an overview of CARVYKTI^® eligibility criteria presented by a Johnson & Johnson oncology clinical educator (OCE)

A group of medical professionals conversing

CARVYKTI^® Long‑Term Monitoring & Shared Care

Get a closer look into the long-term monitoring considerations and transitions of care for patients receiving CARVYKTI^® presented by a Legend Biotech CAR-T clinical educator (Cell Therapy Clinical Educator)

Guidance for complex care moments

Get to know the steps in the CARVYKTI^® treatment journey

From leukapheresis to post-infusion monitoring, learn about how you fit into your patient’s overall CARVYKTI^® experience.

View CARVYKTI^® Treatment Journey

Be the difference: Help your patients get the most from CARVYKTI^®

Review the eligibility criteria for the MyCARVYKTI^® Patient Support Program and explore the opportunities available to your patients who are prescribed CARVYKTI^®.

View Patient Support Program